journal
https://read.qxmd.com/read/38045109/frequencies-of-vkorc1-1639g-a-and-rs397509427-in-patients-on-warfarin-and-healthy-syrian-subjects
#1
JOURNAL ARTICLE
Yara Altawil, Lama A Youssef
BACKGROUND: Vitamin K epoxide reductase complex subunit 1 ( VKORC1 ) gene encodes a key enzyme with multiple cellular activities, namely, the reduction of vitamin K to its active form. VKORC1 -1639G>A (rs9923231) is a common single nucleotide polymorphism with a crucial impact on warfarin dosing and possibly other physiological functions. This study aimed at investigating the frequencies of VKORC1 -1639G>A alleles and genotypes in Syrian healthy subjects and patients on warfarin for different indications...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/38024105/role-of-k-and-ca-2-channels-in-the-vasodilator-effects-of-plectranthus-barbatus-brazilian-boldo-in-hypertensive-rats
#2
JOURNAL ARTICLE
Jeniffer Cristóvão Moser, Rita de Cássia Vilhena da Silva, Philipe Costa, Luisa Mota da Silva, Nadla Soares Cassemiro, Arquimedes Gasparotto Junior, Denise Brentan Silva, Priscila de Souza
Plectranthus barbatus , popularly known as Brazilian boldo, is used in Brazilian folk medicine to treat cardiovascular disorders including hypertension. This study investigated the chemical profile by UFLC-DAD-MS and the relaxant effect by using an isolated organ bath of the hydroethanolic extract of P. barbatus (HEPB) leaves on the aorta of spontaneously hypertensive rats (SHR). A total of nineteen compounds were annotated from HEPB, and the main metabolite classes found were flavonoids, diterpenoids, cinnamic acid derivatives, and organic acids...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/38024104/circulating-fabp-4-levels-in-patients-with-atherosclerosis-or-coronary-artery-disease-a-comprehensive-systematic-review-and-meta-analysis
#3
JOURNAL ARTICLE
Narges Jalilian, Reza Pakzad, Mahdi Shahbazi, Seyyed-Reza Edrisi, Karimeh Haghani, Mohsen Jalilian, Salar Bakhtiyari
BACKGROUND: Cardiovascular diseases (CDs), notably coronary artery disease (CAD) due to atherosclerosis, impose substantial global health and economic burdens. Fatty acid-binding proteins (FABPs), including FABP-4, have been recently linked to CDs. This study conducted a systematic review and meta-analysis to examine FABP-4 levels in CAD and atherosclerosis patients, exploring their potential links to these conditions. METHODS: A systematic review and meta-analysis were done based on the PRISMA guideline...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/38024103/effect-of-thrombolysis-on-circulating-microparticles-in-patients-with-st-segment-elevation-myocardial-infarction
#4
JOURNAL ARTICLE
Zhe Li, Wei Zhang, Qun-Rang Wang, Yu-Juan Yang, Xin-Hong Liu, Gong Cheng, Feng-Jun Chang
OBJECTIVE: We demonstrated that circulating microparticles (MPs) are increased in patients with coronary heart disease (both chronic coronary syndrome (CCS) and acute coronary syndrome). Whether thrombolysis affects MPs in patients with ST-segment elevation myocardial infarction (STEMI) with or without percutaneous coronary intervention (PCI) is unknown. METHODS: This study was divided into three groups: STEMI patients with thrombolysis ( n = 18) were group T, patients with chronic coronary syndrome ( n = 20) were group CCS, and healthy volunteers ( n = 20) were the control group...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37719172/identifying-factors-for-low-risk-participation-in-alternative-cardiac-rehabilitation-models-for-patients-with-coronary-heart-disease-using-mi-s-scorepad
#5
REVIEW
Eric J Brandt, Joshua Garfein, Chih-Wen Pai, Joseph Bryant, Eva Kline-Rogers, Samantha Fink, Melvyn Rubenfire
INTRODUCTION: Although a recent joint society scientific statement (the American Association of Cardiovascular Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology) suggests home-based cardiac rehab (CR) is appropriate for low- and moderate-risk patients, there are no paradigms to define such individuals with coronary heart disease. METHODS: We reviewed a decade of data from all patients with coronary heart disease enrolled in a single CR center (University of Michigan) to identify the prevalence of low-risk factors, which may inform on consideration for participation in alternative models of CR...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37705934/elevated-serum-total-bilirubin-might-indicate-poor-coronary-conditions-for-unstable-angina-pectoris-patients-beyond-as-a-cardiovascular-protector
#6
JOURNAL ARTICLE
Qi Liang, Yongjian Zhang, Jin Liang
BACKGROUNDS: Serum total bilirubin (STB) is recently more regarded as an antioxidant with vascular protective effects. However, we noticed that elevated STB appeared in unstable angina pectoris (UAP) patients with diffused coronary lesions. We aimed to explore STB's roles in UAP patients, which have not been reported by articles. METHODS AND RESULTS: 1120 UAP patients were retrospectively screened, and 296 patients were finally enrolled. They were grouped by Canadian Cardiovascular Society (CCS) angina grades...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37645544/left-bundle-branch-area-pacing-versus-right-ventricular-pacing-in-patients-with-atrioventricular-block-an-observational-cohort-study
#7
JOURNAL ARTICLE
Zhongxiu Chen, Yuanning Xu, Lingyun Jiang, Ran Zhang, Hongsen Zhao, Ran Liu, Lei Zhang, Yajiao Li, Xingbin Liu
OBJECTIVE: We aim to conduct a comparison of the safety and effectiveness performance between left bundle branch area pacing (LBBAP) and right ventricular pacing (RVP) regimens for patients with atrioventricular block (AVB). METHODS: This observational cohort study included patients who underwent pacemaker implantations with LBBAP or RVP for AVB indications from the 1st of January 2018 to the 18th of November 2021 at West China Hospital. The primary composite outcome included all-cause mortality, lead failure, or heart failure hospitalization (HFH)...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37636560/comparison-of-different-chronic-maintenance-antithrombotic-strategies-in-patients-with-coronary-artery-disease-a-systematic-review-and-network-meta-analysis
#8
REVIEW
Junyan Zhang, Zhongxiu Chen, Yujia Cai, Chen Li, Yong He
BACKGROUND: Optimal antithrombotic therapy during the chronic maintenance period in patients with coronary artery disease (CAD) is unknown. We compared five kinds of mainstream chronic maintenance antithrombotic strategies at least one year after the acute phase: aspirin alone, clopidogrel alone, ticagrelor alone, continued dual antiplatelet therapy (DAPT) for a period of time, and maintenance with aspirin combined with a low-dose anticoagulant such as rivaroxaban. METHODS: Ten randomized, controlled trials were selected using PubMed, Ovid MEDLINE, Embase, and Cochrane library through February 2023...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37588774/drug-coated-balloon-only-strategy-for-de-novo-coronary-artery-disease-a-meta-analysis-of-randomized-clinical-trials
#9
JOURNAL ARTICLE
Wenyi Zhang, Mingduo Zhang, Jinfan Tian, Min Zhang, Yuan Zhou, Xiantao Song
BACKGROUNDS: Many clinical trials have demonstrated the value of drug-coated balloons (DCB) for in-stent restenosis. However, their role in de novo lesions is not well documented. The aim of this study is to evaluate the safety and efficacy of the DCB-only strategy compared to other percutaneous coronary intervention strategies for de novo coronary lesions. METHODS: The PubMed, Embase, Web of Science, and Cochrane Library Central Register of Controlled Trials (CENTRAL) electronic databases were searched for randomized controlled trials published up to May 6, 2023...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37496726/heart-failure-with-preserved-left-ventricular-ejection-fraction-a-complex-conundrum-simply-not-limited-to-diastolic-dysfunction
#10
REVIEW
Angel Lopez-Candales, Talal Asif, Khalid Sawalha, Nicholas B Norgard
Over the last two decades, the changing paradigm of heart failure with preserved ejection fraction (HFpEF) has transformed our understanding not only of the pathophysiology of this clinical entity but also the diagnostic and therapeutic approaches aimed at treating this complex patient population. No longer HFpEF should be seen as simply left ventricular diastolic dysfunction but as a group of that in addition of having small and thick left ventricles with abnormal diastolic filling patterns as their main pathophysiologic abnormality; they also have whole host of different abnormalities...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37404774/water-based-exercises-on-peak-oxygen-consumption-exercise-time-and-muscle-strength-in-patients-with-coronary-artery-disease-a-systematic-review-with-meta-analysis
#11
REVIEW
Alana Lalucha Andrade Guimarães, Mansueto Gomes-Neto, Lino Sérgio Rocha Conceição, Micheli Bernardone Saquetto, Caroline Oliveira Gois, Vitor Oliveira Carvalho
BACKGROUND: There is a growing use of water-based exercises in cardiac rehabilitation programs. However, there is little data concerning the effects of water-based exercise on the exercise capacity of coronary artery disease (CAD) patients. OBJECTIVE: To perform a systematic review to investigate the effects of water-based exercise on peak oxygen consumption, exercise time, and muscle strength in patients with CAD. METHODS: Five databases were searched to find randomized controlled trials that evaluated the effects of water-based exercise for coronary artery disease patients...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37388276/the-regulation-network-of-glycerolipid-metabolism-as-coregulators-of-immunotherapy-related-myocarditis
#12
JOURNAL ARTICLE
Xiguang Yang, Xiaopeng Duan, Zhenglin Xia, Rui Huang, Ke He, Guoan Xiang
BACKGROUND: To date, immunotherapy for patients with malignant tumors has shown a significant association with myocarditis. However, the mechanism of metabolic reprogramming changes for immunotherapy-related cardiotoxicity is still not well understood. METHODS: The CD45+ single-cell RNA sequencing (scRNA-seq) of the Pdcd1-/- Ctla4+/- and wild-type mouse heart in GSE213486 was downloaded to demonstrate the heterogeneity of immunocyte atlas in immunotherapy-related myocarditis...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37313545/statin-eligibility-according-to-2013-acc-aha-and-uspstf-guidelines-among-jordanian-patients-with-acute-myocardial-infarction-the-impact-of-gender
#13
MULTICENTER STUDY
Rashid Ibdah, Ahmad Alrawashdeh, Sukaina Rawashdeh, Nebras Y Melhem, Ayman J Hammoudeh, Mohamad I Jarrah
The objectives of this study were to evaluate statin eligibility among Middle Eastern patients admitted with acute myocardial infarction (AMI) who had no prior use of statin therapy, according to 2013 ACC/AHA and 2016 USPSTF guidelines, and to compare statin eligibility between men and women. This was a retrospective multicenter observational study of all adult patients admitted to five tertiary care centers in Jordan with a first-time AMI, no prior cardiovascular disease, and no prior statin use between April 2018 and June 2019...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37251271/e-selectin-aav-gene-therapy-promotes-myogenesis-and-skeletal-muscle-recovery-in-a-mouse-hindlimb-ischemia-model
#14
JOURNAL ARTICLE
Antoine J Ribieras, Yulexi Y Ortiz, Yan Li, Nga T Le, Carlos T Huerta, Francesca A Voza, Hongwei Shao, Roberto I Vazquez-Padron, Zhao-Jun Liu, Omaida C Velazquez
The response to ischemia in peripheral artery disease (PAD) depends on compensatory neovascularization and coordination of tissue regeneration. Identifying novel mechanisms regulating these processes is critical to the development of nonsurgical treatments for PAD. E-selectin is an adhesion molecule that mediates cell recruitment during neovascularization. Therapeutic priming of ischemic limb tissues with intramuscular E-selectin gene therapy promotes angiogenesis and reduces tissue loss in a murine hindlimb gangrene model...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37228484/analysis-of-the-efficacy-and-safety-of-coronary-catheterization-through-distal-transradial-access-a-single-center-data
#15
JOURNAL ARTICLE
Huanhuan Wang, Dan Liu, Jidong Guo, Nuerbahati Heisha, Lei Wang, Qiang Zhang, Yihui Han, Xiping Wang, Bo Zhang, Jinqing Yuan, Lijian Gao
BACKGROUND AND AIMS: The distal transradial access (dTRA) is a new puncture site for coronary catheterization. We sought to evaluate the feasibility, safety, and complication rates of using the dTRA for cardiac catheterization in Chinese patients. METHODS: A total of 263 consecutive patients who underwent catheterization through the dTRA were enrolled. The primary endpoint of the study was the rate of conversion to another access site due to the impossibility of successful artery puncture or intubation...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37214130/pulegone-prevents-hypertension-through-activation-of-muscarinic-receptors-and-cyclooxygenase-pathway-in-l-name-induced-hypertensive-rats
#16
JOURNAL ARTICLE
Muryam Abdul Razzaq, Waqas Younis, Muhammad Nasir Hayat Malik, Tariq G Alsahli, Alamgeer, Shah Jahan, Roma Ehsan, Arquimedes Gasparotto Junior, Asifa Bashir
The current study was designed to determine pulegone's antihypertensive and vasoprotective activity in L-NAME-induced hypertensive rats. Firstly, the hypotensive dose-response relationship of pulegone was evaluated in normotensive anesthetized rats using the invasive method. Secondly, the mechanism involved in hypotensive activity was determined in the presence of pharmacological drugs such as atropine/muscarinic receptor blocker (1 mg/kg), L-NAME/NOS inhibitor (20 mg/kg), and indomethacin/COX inhibitor (5 mg/kg) in anesthetized rats...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37187923/mir-135a-regulates-atrial-fibrillation-by-targeting-smad3
#17
JOURNAL ARTICLE
Xueting Fan, Kai Feng, Yonghui Liu, Leixi Yang, Yizhuo Zhao, Liping Tian, Yiqun Tang, Xiaozhi Wang
BACKGROUND: Atrial fibrillation (AF) is the most common arrhythmia in clinical. Atrial fibrosis is a hallmark feature of atrial structural remodeling in AF, which is regulated by the TGF- β 1/Smad3 pathway. Recent studies have implicated that miRNAs are involved in the process of AF. However, the regulatory mechanisms of miRNAs remain largely unknown. This study is aimed at investigating the function and regulatory network of miR-135a in AF. METHODS: In vivo , the plasma was collected from patients with AF and non-AF subjects...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37151221/effect-of-statins-on-major-adverse-cardiovascular-events-in-patients-with-coronary-artery-spasm-a-meta-analysis-of-the-asia-region
#18
JOURNAL ARTICLE
Tian-Jun Zhao, Duan Luo, Xi Jiang, Feng Tang, Hui Jiang
BACKGROUND: Whether statins can reduce major cardiovascular adverse events (MACE) in patients with coronary artery spasm (CAS) is controversial. And most of the relevant research to date has been conducted in Asia. METHODS: We systematically searched electronic databases for studies on the effect of statins on MACE in patients with CAS in Asia and published up to September 2022. We included data on MACE in a statin therapy patient group and a no-statin therapy control group...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37151220/cardioprotection-of-mab2g4-odn-lip-on-myocardial-ischemia-reperfusion-injury-via-inhibiting-the-nf-%C3%AE%C2%BA-b-signaling-pathway
#19
JOURNAL ARTICLE
Zujin Xu, Zhuoran Wei, Yali Zhu, Guoqing Jing, Liufang Chen, Jia Zhan, Yun Wu
Substantial evidence suggests that the interventions of NF- κ B would likely effectively prevent inflammatory response and reduce myocardial damage in the ischemic myocardium. And the NF-кB decoy ODN is a specific inhibitor that suppresses the expression of NF- κ B. Herein, we revealed the effect and possible mechanism of mAb2G4/ODN/lip on myocardial ischemia-reperfusion injury (MI/RI). As shown in the results, post-treatment with mAb2G4/ODN/lip improved the impaired histological morphology in the MI/RI model and elevated cell viability in the H/R model...
2023: Cardiovascular Therapeutics
https://read.qxmd.com/read/37113506/efficacy-of-acupuncture-in-the-treatment-of-essential-hypertension-an-overview-of-systematic-reviews-and-meta-analyses
#20
REVIEW
Maoxia Fan, Guohua Dai, Runmin Li, Xiaoqi Wu
BACKGROUND: Acupuncture is widely used in the clinical treatment of essential hypertension (EH). This overview is aimed at summarizing current systematic reviews of acupuncture for EH and assessing the methodological bias and quality of evidence. METHODS: Two researchers searched and extracted 7 databases for systematic reviews (SRs)/meta-analyses (MAs) and independently assessed the methodological quality, risk of bias, reporting quality, and quality of evidence of randomized controlled trials (RCTs) included in the SRs/MAs...
2023: Cardiovascular Therapeutics
journal
journal
41804
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.